News
Pinco Biotherapeutics Announces Strategic Investment from Advisor Anton Dormer, MD, MS
Investment Supports Advancement of DNA Plasmid–Based Therapy for Neuropathic Pain
Pinco Biotherapeutics Expands Advisory Board with Regulatory and Commercial Leadership
Appointments Strengthen Regulatory Strategy and Commercial Planning During Optimization
Pinco Biotherapeutics Presents at 2025 BioHealth Capital Region Forum
Presentation Showcases Preclinical Progress and Expands Mid-Atlantic Investor and Partner Engagement
Pinco Biotherapeutics Presents at Seed-2-Table Life Sciences Pitch Event
Investor-Focused Pitch Advances Capital Formation and Strategic Dialogue for Nav1.7 Plasmid Platform
Pinco Biotherapeutics Selected for Science Center’s Capital Readiness Program Cohort 8
Program Participation Enhances Investor Positioning and Refines Development Milestones
Pinco Biotherapeutics Participates in BIO International Convention 2025 with Support from MD Dept. of Commerce
Participation Strengthens Strategic Partnerships and Industry Visibility for Nav1.7 Gene Therapy Platform